EMA recommends expanding compassionate use of Gilead's COVID-19 drug

The European Medicines Agency (EMA) on Monday recommended that Gilead Sciences Inc's experimental drug for the new coronavirus be given under compassionate use to patients other than those undergoing invasive mechanical ventilation.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news